Skip to main content

Table 3 Incontinence Quality of Life questionnaire: total score.

From: Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial

   

I-QOL Total Score

Treatment group (N)†

Time point

n‡

Mean I-QOL

Mean change in I-QOL from baseline§

95% CI for treatment difference in I-QOL

P

Placebo (61)

Baseline

59

61.23

   
 

Endpoint

 

74.56

13.33

  

Duloxetine (60)

Baseline

52

62.65

   
 

Endpoint

 

76.29

13.64

(-4.77,6.78)

.732

  1. †N = number randomized.
  2. ‡n = number with diary data available for specified analysis.
  3. §Baseline is the last nonmissing visit score on or before randomization.
  4. ¶95% CI for treatment difference.
  5. Abbreviations: CI = confidence interval; I-QOL = Incontinence Quality of Life questionnaire